Anika Therapeutics
ANIK
ANIK
125 hedge funds and large institutions have $360M invested in Anika Therapeutics in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 49 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.74% less ownership
Funds ownership: 96.45% → 89.71% (-6.7%)
24% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 49
Holders
125
Holding in Top 10
1
Calls
$2.47M
Puts
$240K
Top Buyers
| 1 | +$5.85M | |
| 2 | +$3.55M | |
| 3 | +$2.14M | |
| 4 |
BlackRock
New York
|
+$2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.93M |
Top Sellers
| 1 | -$18.3M | |
| 2 | -$15.3M | |
| 3 | -$9.14M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$5.9M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$3.34M |